News Daily News One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says Michael O'Riordan March 06, 2020
News Conference News CRT 2020 Operator Volume Matters in Left Main PCI: BCIS Analysis Michael O'Riordan March 05, 2020
News Daily News CRT 2020 Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease Michael O'Riordan March 04, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Daily News BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns Michael O'Riordan February 21, 2020
News Daily News Acute MI Symptom Clustering Differs in Men and Women: VIRGO Michael O'Riordan February 21, 2020
News Daily News Nearly Half of Diabetic Patients Struggle to Pay Medical Bills Michael O'Riordan February 12, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Daily News Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks Michael O'Riordan February 05, 2020
News Daily News SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE Michael O'Riordan February 03, 2020
News Daily News Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews Michael O'Riordan January 31, 2020
News Daily News European Regulators Approve First Transcatheter MV Replacement Device Michael O'Riordan January 30, 2020
News Daily News TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State Michael O'Riordan January 22, 2020
News Daily News Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA Michael O'Riordan January 21, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals Michael O'Riordan January 16, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020